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Neuropeptide and peptide hormone secretion from
neural and endocrine cells occurs by Ca2+-triggered
dense-core vesicle exocytosis. The membrane
fusion machinery consisting of vesicle and plasma
membrane SNARE proteins needs to be assembled
for Ca2+-triggered vesicle exocytosis. The related
Munc13 and CAPS/UNC31 proteins that prime
vesicle exocytosis are proposed to promote SNARE
complex assembly. CAPS binds SNARE proteins
and stimulates SNARE complex formation on lipo-
somes, but the relevance of SNARE binding to
CAPS function in cells had not been determined.
Here we identify a core SNARE-binding domain in
CAPS as corresponding to Munc13 homology
domain-1 (MHD1). CAPS lacking a single helix in
MHD1 was unable to bind SNARE proteins or to
support the Ca2+-triggered exocytosis of either
docked or newly arrived dense-core vesicles. The
results show that MHD1 is a SNARE-binding domain
and that SNARE protein binding is essential for CAPS
function in dense-core vesicle exocytosis.
INTRODUCTION
The release of neuropeptides and peptide hormones in neurons
and endocrine cells by Ca2+-dependent vesicle exocytosis is
a tightly controlled process catalyzed by SNARE protein
complexes (Jahn and Scheller, 2006). Vesicle exocytosis
employs the v-SNARE protein VAMP-2 (aka synaptobrevin) on
the vesicle that assembles with the plasma membrane t-SNARE
proteins syntaxin-1 and SNAP-25 into four-helix bundle
complexes that bridge membranes to promote bilayer fusion
(Sutton et al., 1998; Weber et al., 1998). To account for the rapid
fusion of dense-core vesicles following Ca2+ influx in chromaffin
cells, it was proposed that SNARE complexes are assembled in
advance on docked vesicles during a priming step (Rettig and
Neher, 2002). Undocked vesicles in endocrine cells also undergo
rapid evoked exocytosis, which indicates that priming can also
occur immediately upon vesicle arrival at the plasmamembrane.
Indeed, studies in pancreatic b cells detected preassembled
SNARE complexes at sites of rapid exocytosis as well as SNARE254 Cell Metabolism 14, 254–263, August 3, 2011 ª2011 Elsevier Inccomplex assembly immediately preceding exocytosis that fol-
lowed Ca2+ influx (Takahashi et al., 2010). The molecular basis
for vesicle priming and SNARE complex assembly is poorly
understood.
Genetic and biochemical studies indicate that CAPS (Ca2+-
dependent activator protein for secretion) and related Munc13
proteins prime vesicle exocytosis (Stevens and Rettig, 2009;
Wojcik and Brose, 2007). CAPS (aka CADPS, UNC31) is
a neural/endocrine-specific protein that reconstitutes Ca2+-trig-
gered dense-core vesicle exocytosis in permeable neuroendo-
crine cells (Ann et al., 1997; Walent et al., 1992) and in purified
plasma membranes with docked dense-core vesicles (Martin
and Kowalchyk, 1997), which indicates function after vesicle
docking. In accord with this, neuroendocrine cells lacking
CAPS exhibit impaired vesicle exocytosis without impaired
vesicle docking (Fujita et al., 2007; Grishanin et al., 2004; Liu
et al., 2008; Nojiri et al., 2009). In chromaffin and pancreatic
b cells, CAPS was shown to function at a vesicle priming step
(Elhamdani et al., 1999; Liu et al., 2008; Olsen et al., 2003;
Speidel et al., 2008). Reductions in docked dense-core vesicles
in pancreatic b cells or C. elegans neurons lacking CAPS may
also indicate a role in stabilizing vesicle docking (Hammarlund
et al., 2008; Speidel et al., 2008). The mechanism that CAPS
utilizes at a late step in dense-core vesicle exocytosis is not fully
understood.
CAPS contains several possible functional domains (Fig-
ure 1A). A central pleckstrin homology (PH) domain binds
PI(4,5)P2 for plasma membrane recruitment (Grishanin et al.,
2002, 2004). A region in the C-terminal half of CAPS, which
exhibits homology (20% identity, 40% similarity) to a region in
the C-terminal half of Munc13-1, contains two contiguous
annotated homology domains, DUF1041 (domain of unknown
function 1041; pfam 06292) and MHD1 (Munc13 homology
domain-1) (Koch et al., 2000), referred to as the DAMH
(DUF1041 and MHD1) domain. The DAMH domain is conserved
in all CAPS/Munc13 family proteins, but its functional role is
unknown.
Recent studies showed that CAPS stimulates trans SNARE
complex formation on liposomes and is able to promote the
SNARE-dependent fusion of liposomes that contain PI(4,5)P2
(James et al., 2008, 2009). CAPS was also found to bind to
each of the three exocytic SNARE proteins, syntaxin-1, SNAP-
25, and VAMP-2 (Daily et al., 2010). These findings suggest
possible mechanisms for CAPS in driving SNARE complex
assembly during priming. However, the domain in CAPS respon-
sible for SNARE binding and the relevance of SNARE binding to.
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tify a SNARE-binding region in CAPS within the DAMH domain
corresponding to MHD1 and show that it is essential for CAPS
activity at a late step in dense-core vesicle exocytosis.
RESULTS
The SNARE-Binding Region in CAPS Corresponds
to the DAMH Domain
CAPS interacts with membrane-integrated heterodimeric
t-SNARE complexes comprised of syntaxin-1 and SNAP-25
(Daily et al., 2010). To identify the t-SNARE-binding domain in
CAPS, fusion proteins across the full length of CAPSwere gener-
ated (Figure 1A). These were designed to correspond to folded
domains in the protein based on fragments generated by limited
protease digestion (Loyet et al., 1998). The GST-fusion proteins,
each at 0.2 mM, were incubated with t-SNARE-containing lipo-
somes, and bound proteins were separated from unbound by
buoyant density gradient centrifugation. The fusion protein cor-
responding to the DAMH domain (CAPS 859–1073) efficiently
bound to membrane-integrated t-SNAREs, whereas other fusion
proteins did not (Figure 1B). Under these conditions, the binding
of fusion proteins to protein-free liposomes was negligible (data
not shown).
Binding studies over a range of DAMHdomain protein concen-
trations at a constant concentration of t-SNARE-containing
liposomes revealed a dissociation constant Kd = 177 ± 47 nM
(Figure 1C), which is similar to that for full-length CAPS binding
to t-SNARE proteins (Daily et al., 2010). Full-length CAPS effec-
tively and fully competed with the DAMH domain protein for
binding to t-SNAREs (Figure 1D). Conversely, t-SNARE binding
by full-length CAPS was effectively competed by the DAMH
domain protein (Figure S1A). The identification of the DAMH
domain protein as the only t-SNARE-binding fragment in CAPS
and its ability to fully compete for CAPS binding indicate that
the DAMHdomain is themajor site in CAPS for t-SNARE binding.
The DAMH Domain Interacts with Individual
t-SNARE Proteins
We characterized the t-SNARE-binding properties of the DAMH
domain protein to compare with those of the full-length CAPS
protein. The DAMH domain protein interacted with the individual
membrane-associated t-SNARE proteins, syntaxin-1 and
SNAP-25, to a similar extent and exhibited 2-fold greater binding
to membrane-integrated heterodimeric t-SNARE complexes
(Figure 1E). This indicated that syntaxin-1 and SNAP-25 each
contribute a site for DAMH domain protein binding in heterodi-
meric t-SNARE complexes. Syntaxin-1 contains several
domains (Figure 1F, lower), including an N-terminal Habc
domain, a membrane-proximal helical H3 domain (SNARE
motif), and a C-terminal transmembrane domain. To determine
the binding site for the DAMH domain protein on syntaxin-1,
we introduced a thrombin cleavage site between the Habc and
H3 domains (Parlati et al., 1999). DAMH domain protein binding
to heterodimeric t-SNARE complexes was similar with or without
thrombin cleavage (Figure 1F), showing that the binding site for
the DAMH domain protein is in the C-terminal H3-linker region
of syntaxin-1. Thus, the DAMH domain protein appeared to
exhibit the same characteristics of full-length CAPS in bindingCelto individual t-SNARE proteins and to the H3-linker region in
syntaxin-1 (Daily et al., 2010).
Competition binding studies confirmed the preferential binding
of the DAMH domain protein to C-terminal but not N-terminal
regions of syntaxin-1 (Figure S1B). Moreover, these competition
studies revealed that the DAMHdomain protein contains a single
site for binding t-SNARE proteins or two distinct sites (one for
syntaxin-1 and one for SNAP-25) that overlap.
The DAMH Domain Interacts with VAMP-2
Full-length CAPS interacts with each of the exocytic SNARE
proteins, including VAMP-2 (Daily et al., 2010), but the binding
site in CAPS for VAMP-2 has not been identified. We found
that the DAMH domain protein bound to membrane-integrated
VAMP-2 with a Kd = 212 ± 73 nM (Figure 2A). The low stoichiom-
etry of binding may be due to the limited folding of VAMP-2 in
isolation on membranes (Ellena et al., 2009). The DAMH domain
is likely the main VAMP-2 binding site in full-length CAPS
because the DAMH domain protein effectively competed with
full-length CAPS for binding to membrane-integrated VAMP-2
(Figure S1C). The results indicate that the DAMH domain protein
interacts with each of the exocytic SNARE proteins, as does full-
length CAPS.
We found that the DAMH domain protein also interacted with
ternary SNARE complexes that were formed by binding soluble
VAMP-2 to t-SNARE liposomes. DAMH domain protein binding
to ternary SNARE complexes (with or without bound com-
plexin-1) was similar to binding to t-SNARE complexes
(Figure 2B). This indicated that the binding sites for the DAMH
domain protein on syntaxin-1 H3 and SNAP-25 remain acces-
sible after VAMP-2 is bound. It was noteworthy that VAMP-2
incorporation into t-SNARE complexes to form ternary SNARE
complexes did not contribute an additional binding site for the
DAMH domain protein (Figure 2B). This likely indicates that the
binding site for the DAMH domain on VAMP-2 is masked when
VAMP-2 is bound into the ternary SNARE complex. These results
may indicate that CAPS interacts with VAMP-2 prior to but not
after the formation of a ternary SNARE complex.
The preceding studies revealed that the 215 residue DAMH
domain protein recapitulates many of the SNARE-binding
properties of the full-length 1289 residue CAPS protein. In
competition binding studies (Figure S1D), we found that
v-SNARE and t-SNARE binding by the DAMH domain protein
was likely mediated through distinct but overlapping sites.
A Helix within MHD1 Mediates SNARE Binding
The DAMH domain is predicted to be largely helical, with 4–5
a helices joined by short unstructured segments. To identify
a core SNARE-binding domain in CAPS, we generated fusion
proteins that span one or several of the predicted helices for
testing t-SNARE and v-SNARE binding (Figures 2C and 2D).
A fusion protein corresponding to part of MHD1 (residues
929–997) was found to interact with t-SNARE- or with
v-SNARE-containing liposomes. Thus, a core SNARE-binding
domain appeared to consist of a 69 residue portion of
MHD1. The larger of the predicted helices in this region (box in
Figure 2C) contained sequences that exhibit homology (67%
similar) to the N-terminal half of the SNARE motif in VAMP-2
(Figure 2E).l Metabolism 14, 254–263, August 3, 2011 ª2011 Elsevier Inc. 255
Figure 1. SNARE Binding in CAPS Localizes to DAMH Domain
(A) Schematic of CAPS GST fusion proteins. Black boxes indicate C2, PH, and DAMH domains. Gray box indicates homology to Munc13.
(B) GST fusion proteins at 0.2 mM were assayed for binding to 0.5 mM t-SNAREs in PC liposomes. Liposome-bound proteins were isolated from gradients and
analyzed on SDS-PAGE forwestern blottingwithGST antibody (top panel) or syntaxin-1 antibody (bottompanel). CAPS(859-1073) corresponds to DAMHprotein.
(C) Binding to t-SNAREs in PC liposomes was conducted at the indicated concentrations of MBP-DAMH. Liposome-bound MBP-DAMH was analyzed by
SDS-PAGE with SYPRO Ruby staining and densitometry. Best-fit curve indicated binding parameters: Kd = 177 ± 47 nM and Bmax = 0.3 mol CAPS bound/mol
t-SNAREs (mean ± SEM, n = 3).
(D) Competition for binding of 0.3 mM GST-DAMH to 0.5 mM t-SNAREs in PC liposomes was conducted for indicated CAPS concentrations. Liposome-bound
proteins were analyzed by western blotting with CAPS antibody (top and middle panels) or syntaxin-1 antibody (bottom panel) and by densitometry. Competition
by 2 mM CAPS in duplicate with ranges is indicated.
(E) 0.5 mM t-SNAREs, syntaxin-1, or SNAP-25 in liposomes and their protein-free counterparts were incubated with 0.5 mMGST-DAMH. Bound GST-DAMH was
analyzed by SDS-PAGE and SYPRO Ruby staining. SNARE binding by GST-DAMH, normalized to the SNARE content of the liposomes, was expressed as mean
values ± SEM (n = 6).
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dues 952–997. A full-length CAPS protein lacking this region
(Figure 2F) was expressed, purified, and tested for its ability to
interact with membrane-integrated t-SNAREs by buoyant
density flotation (Figure 2G). Whereas a significant fraction of
wild-type CAPS protein bound to t-SNARE-containing lipo-
somes, there was negligible binding of the CAPS(D952-997)
protein to t-SNARE-containing liposomes (Figure 2G). The
CAPS(D952-997) protein retained other properties of the wild-
type protein such as lipid binding and mobility on native gels
(data not shown), suggesting that it was properly folded. The
results indicate that t-SNARE binding by CAPS requires a helix
within MHD1.
Functional Analysis of SNARE-Binding-Deficient
CAPS Mutant
The function of CAPS can be assessed by its activity in reconsti-
tuting Ca2+-dependent vesicle exocytosis in permeable neuro-
endocrine cells (Grishanin et al., 2004). Whereas 20 nM wild-
type CAPS effectively reconstituted Ca2+-triggered vesicle
exocytosis in permeable PC12 cells, the activity of 40 nM
CAPS(D952-997) was greatly reduced (Figure 3A). When tested
together, the CAPS(D952-997) protein significantly reduced the
activity of the wild-type CAPS protein, which indicates that the
mutant protein exhibits dominant inhibitory properties. Overall,
the CAPS(D952-997) protein exhibited a strong loss of function
for reconstituting Ca2+-dependent vesicle exocytosis in perme-
able cells that was comparable to its strong loss of SNARE
binding.
These data indicated that sequences in MHD1 are necessary
for CAPS activity. Because the DAMH domain protein recapitu-
lated many of the SNARE-binding properties of CAPS, we also
determined whether the DAMH domain might be sufficient for
CAPS function. However, we failed to detect a stimulatory effect
of the DAMH domain protein in the permeable cell assay (Fig-
ure 3B). By contrast, increasing concentrations of the DAMH
domain protein significantly inhibited CAPS stimulation of
Ca2+-triggered catecholamine release. These studies show
that sequences within the DAMH domain are necessary but
not sufficient for CAPS activity.
We further tested the activity of the CAPS(D952-997) protein to
support evoked vesicle exocytosis in live PC12 cells. We first
determined the localization of CAPS(D952-997) compared to
wild-type CAPS in PC12 cells by TIRF microscopy (Figure 3C).
Wild-type CAPS distributes as clusters that colocalize with clus-
ters of syntaxin-1 (Figure 3C, upper). By contrast, CAPS(D952-
997) was diffusely distributed and failed to localize in clusters
while syntaxin-1 clusters exhibited a normal distribution (Fig-
ure 3C, lower). These results were consistent with a loss of
SNARE binding for the CAPS(D952-997) protein.
To test the activity of CAPS proteins in evoked vesicle exocy-
tosis, we expressed brain-derived neurotrophic factor (BDNF)-
GFP to directly image plasma membrane-proximal dense-core
vesicles by TIRF microscopy (Figure 4A). Exocytosis of single(F) 0.3 mMGST-DAMH was incubated with 0.5 mM t-SNAREs or thrombin-cleaved
blotting with CAPS antibody (top panel), syntaxin-1 antibody (middle panel), or SN
the SNARE content of the liposomes, was expressed asmean values ± SEM (n = 7
is indicated by arrow.
Celvesicles was detected as increased BDNF-GFP fluorescence
due to neutralization of an acidic vesicle upon fusion pore forma-
tion (Figure 4C). Depolarization of PC12 cells stimulates Ca2+
influx, which promotes a rapid increase in the number of vesicle
exocytic events (Figure 4D). The shRNA-mediated downregula-
tion of CAPS to 10% of control levels (Figure 4G) strongly
reduced the number of evoked exocytic events (Figure 4D).
Rescue studies were conducted with plasmids encoding
shRNA-resistant CAPS-tagRFP proteins to simultaneously
monitor protein expression and function. Re-expression of
wild-type CAPS restored evoked exocytosis close to levels
of wild-type cells (Figure 4E). By contrast, expression of
CAPS(D952-997) at levels similar to those of wild-type CAPS
(Figure 4H) failed to restore evoked exocytosis (Figure 4E).
Wild-type and CAPS knockdown cells (data not shown) as well
as cells re-expressing wild-type CAPS or the CAPS(D952-997)
protein had similar numbers of membrane-proximal dense-
core vesicles (Figures 4A and 4B), which indicated that the
loss of function occurred at a step following vesicle delivery
to the plasma membrane. Most (75%) exocytic events eli-
cited by depolarization in PC12 cells arise from membrane-
proximal vesicles (termed residents), but there are also some
(25%) exocytic events from vesicles that approach the
plasma membrane during stimulation (termed nonresidents)
(Figure 4F). Resident and nonresident exocytic events exhibit
similar time courses following stimulation (Figure S2). In spite
of large differences in the total number of vesicle exocytic
events in cells depleted for CAPS or rescued with wild-type
CAPS or CAPS(D952-997) (Figures 4D and 4E), there was no
significant difference in the proportion of resident and nonres-
ident vesicle fusion events (Figure 4F). This indicates that CAPS
is required for the exocytosis of both resident as well as newly
arrived nonresident vesicles, which suggests a function for
CAPS after vesicle arrival at the plasma membrane. These
results contrast with a reported preferential inhibitory effect
of overexpressed Doc2a mutants on resident but not nonresi-
dent vesicle exocytosis (Sato et al., 2010). The kinetics of indi-
vidual fusion events did not differ for CAPS knockdown cells
rescued by wild-type CAPS or CAPS(D952-997) (Figure 4C).
This suggests that CAPS participates in determining vesicle
fusion probabilities but is not directly involved in the fusion
process. Our results indicate that CAPS lacking part of the
SNARE-binding MHD1 domain fails to support evoked vesicle
exocytosis, which implies that SNARE binding is essential for
CAPS function.
DISCUSSION
SNARE proteins catalyze membrane fusion as four-helix bundle
complexes that bridge vesicle and plasma membranes. The
timing of SNARE complex assembly relative to evoked vesicle
exocytosis has been assessed in pancreatic b cells (Takahashi
et al., 2010), but the mechanisms that initiate SNARE complex
assembly prior to exocytosis remain to be clarified. CAPS bindst-SNAREs in PC liposomes, and the bound fraction was analyzed by western
AP-25 antibody (bottom panel). SNARE binding by GST-DAMH, normalized to
). Diagram of the domain organization of syntaxin-1 with thrombin cleavage site
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Figure 2. Localization of SNARE Binding to MHD1
(A) Indicated concentrations of MBP-DAMH were incubated with 0.5 mMVAMP-2 in PC liposomes, and liposome-bound protein was quantified by SYPRO Ruby
staining (mean ± SEM, n = 3). A best-fit curve for one binding site indicated Kd = 212 ± 73 nM and Bmax = 0.09 mol bound DAMH/mol VAMP-2.
(B) t-SNAREs, ternary complex (t-SNAREs + VAMP-2[1-94]), or ternary complex with bound complexin-1 at 0.5 mM in PC liposomes was incubated with 0.3 mM
GST-DAMH. Liposome-boundGST-DAMHwas analyzed bySDS-PAGEwith SYPRORuby staining. RelativeGST-DAMHbinding is shown asmean ±SEM (n = 6).
(C) Schematic of the MBP-CAPS fusion proteins within DAMH domain with predicted secondary structure indicated. Panel on the right summarizes binding to
t-SNARE- and v-SNARE-containing liposomes for each protein.
(D) MBP-CAPS proteins at 0.2 mM were incubated with 0.5 mM t-SNAREs in PC liposomes, and gradient fractions were analyzed by western blotting with MBP
antibody. Liposome-bound protein was in fraction 2. Similar studies were conducted with v-SNARE liposomes.
(E) Schematic of similarity for helical segments in MHD1 (CAPS957-983) and VAMP-2(31-56) from ClustalW alignment (* indicates identity; :/. indicates strongly/
weakly similar). Amino acids in VAMP-2 in interacting layers of SNARE complexes are boxed.
(F) Schematic of CAPS wild-type and CAPS(D952-997) mutant.
(G) Full-length CAPS and CAPS(D952-997) at 0.2 mM were incubated with 0.5 mM t-SNAREs in PC liposomes. Bound protein (fractions 1 and 2) was separated
from free (fractions 5 and 6) by gradient flotation and analyzed by immunoblotting with CAPS or syntaxin-1 antibody.
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Figure 3. Properties of CAPS(D952-997) Mutant
(A) Testing CAPS(D952-997) for reconstitution of Ca2+-triggered vesicle exocytosis in permeable PC12 cells. Permeable cells were incubated at 35C for the
indicated times with 20 nM CAPS, 40 nM CAPS(D952-997), or both after injection of 1 mMCa2+ at zero time. The rotating disk electrode detected norepinephrine
as a voltage.
(B) Testing a DAMH domain protein for reconstitution of Ca2+-triggered vesicle exocytosis in permeable PC12 cells. Studies were conducted as in (A) with 10 nM
CAPS, 30 mM DAMH protein, or CAPS with varying DAMH protein concentrations as indicated.
(C) PC12 cells expressing CAPS-mKate2 or CAPS(D952-997)-mKate2 as indicated with syntaxin-1-EGFP were imaged by two-channel TIRF microscopy
(left panels). Representative line scans (right panels) between the arrowheads indicated on the left panels were taken after thresholding images to cover multiple
syntaxin-1 clusters. These indicated that CAPS-mKate2 clusters colocalized with syntaxin-1-EGFP clusters (upper right panel), whereas CAPS(D952-997)-
mKate2 failed to localize to the plasma membrane with syntaxin-1-EGFP clusters (lower right panel). Colocalization was quantified in several (n = 12) images
similar to those in the left panels as the thresholded Mander’s split colocalization coefficient where 1.0 is full colocalization and 0.0 is no colocalization. Syntaxin-
1-EGFP clusters colocalized with CAPS-mKate2 puncta with a coefficient = 0.36 ± 0.08. This was substantially reduced (to 0.02 ± 0.01) for syntaxin-1-EGFP
colocalization with CAPS(D952-997)-mKate2.
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complex formation on liposomes (James et al., 2009), which
suggests that CAPS could function to assemble SNARE
complexes in advance of or at the time of fusion. The current
work showed that CAPS binding to SNARE proteins is essential
for evoked vesicle exocytosis. Future studies will need to directly
assess the role of CAPS in the assembly of SNARE complexes in
neuroendocrine cells.
The principal SNARE-binding domain in CAPS was identified
as corresponding to the DAMH domain, which consists of twoCeladjacent (DUF1041 and MHD1) homology domains of unknown
function. The SNARE-binding characteristics of a DAMH domain
protein were remarkably similar to those of full-length CAPS,
which include interactions with each of the exocytic SNARE
proteins and the property of binding the C-terminal SNAREmotif
of syntaxin-1. A core SNARE-binding region in the DAMH
domain appeared to correspond to MHD1. The lack of t-SNARE
binding by the CAPSD952-997 mutant, which lacks a predicted
helix within MHD1, is consistent with this assignment. The loss of
function of the CAPSD952-997 protein in cells was accompaniedl Metabolism 14, 254–263, August 3, 2011 ª2011 Elsevier Inc. 259
Figure 4. SNARE Binding Is Essential for CAPS Function
(A–C) PC12 cells were transfectedwith a plasmid encoding BDNF-GFP, and CAPS-1 was downregulated by expression of an shRNA plasmid. Rescue constructs
were used to re-express wild-type CAPS or CAPS(D952-997). TIRF view of BDNF-GFP-containing dense-core vesicles in cells rescued with wild-type CAPS or
CAPS(D952-997) is shown (A). Shown in (B) are the number of vesicles in the evanescent field for cells in (A) plotted as density (from five cells). Identical vesicle
densities were found in wild-type and CAPS knockdown cells (data not shown). Shown in (C), 56 mM K+-containing buffer stimulates Ca2+ influx and promotes
vesicle exocytosis detected as increased fluorescence of BDNF-GFP. Compiled profiles for single events (with maximal fluorescence aligned at t = 0) are shown
for rescue with wild-type CAPS (n = 150) and CAPS(D952-997) (n = 25). No significant differences were observed.
(D) CAPS downregulation by shRNA resulted in a 5-fold reduction in the number of exocytic events evoked by 56 mM K+ depolarization applied at zero time.
Recordings were at 4 Hz, and events binned at each 15 s are shown (means ± SEM, n = 11 cells).
(E) Transfection of a pcDNA3.1-CAPS-tagRFP harboring silent mutations into CAPS downregulated PC12 cells restored evoked exocytosis with wild-type CAPS
but failed to do so for CAPS(D952-997) (means ± SEM, n = 12–13 cells).
(F) Analysis of fusion events from resident and nonresident vesicles. Lower panel shows representative fusion events recorded at 4 Hz from resident or
nonresident vesicles defined by whether vesicle fluorescence was evident within 0.5 s of fusion. The proportion of resident or nonresident fusion events
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losses in resident and nonresident vesicle fusion events, and
a marked reduction in the number of vesicle fusion events
without a change in their kinetics. The results indicate that
SNARE binding by MHD1 is essential for CAPS function at
a step following vesicle delivery to the plasma membrane.
This work identifies MHD1 as a SNARE-binding domain. A
DAMH domain with MHD1 is present in all members of the
CAPS/Munc13 family of proteins, but whether MHD1 mediates
SNARE binding by Munc13 proteins is currently uncertain. The
interaction of a C-terminal region of Munc13-1 with an
N-terminal domain of syntaxin-1 was reported in yeast two-
hybrid studies (Betz et al., 1997), but biochemical studies were
unable to confirm this (Basu et al., 2005; Ma et al., 2011). Several
mutations in Munc13-1/UNC13 including in MHD1 were identi-
fied that decreased binding to N-terminal syntaxin fragments
(Madison et al., 2005; Stevens et al., 2005). However, recent
studies suggested that the C terminus of Munc13-1 may actually
interact with the H3 SNARE domain of syntaxin (Ma et al., 2011),
as does CAPS (Daily et al., 2010). Studies are needed to deter-
mine whether the DAMH domain and MHD1 mediate SNARE
binding in Munc13 proteins. The main mechanism proposed
for Munc13-1 is binding to syntaxin-1 to enable a transition
fromaMunc18-1-bound closed conformation to an open confor-
mation that allows SNARE complex assembly (Ma et al., 2011;
Wojcik and Brose, 2007). It is currently unclear whether CAPS
functions similarly. Munc18-1 enhances CAPS binding to syn-
taxin-1, which suggests there may be functional interactions
(Daily et al., 2010).
Full-length CAPS binds helical SNARE motifs of syntaxin-1,
SNAP-25, and VAMP-2, but it exhibits specificity in binding to
only a subset of exocytic SNARE protein isoforms (Daily et al.,
2010). The current work showed that the DAMH domain protein
interactswith the SNARE plus linkermotif of syntaxin-1 aswell as
with SNAP-25 and VAMP-2. Competition binding studies sug-
gested that the DAMH domain contains distinct but overlapping
binding sites for v- and t-SNAREs. This region included
sequences with homology to the N-terminal half of the SNARE
motif in VAMP-2, which implies that part of the SNARE-binding
region in CAPS has SNARE motif-like characteristics. However,
the role of this VAMP-like region in CAPS is uncertain. It is
unlikely that the VAMP-like motif in CAPS binds t-SNAREs in
a manner similar to VAMP-2 because VAMP-2 prebound to
t-SNAREs did not prevent DAMH domain protein binding. The
VAMP-like segment in CAPS is part of a larger helical region,
and it could play a role as a coiled-coil trigger site, as was sug-
gested for cognate sequences of VAMP-2 (Wiederhold et al.,
2010).
There is precedent for a SNARE motif-like domain residing in
SNARE regulatory proteins. In the tethering protein p115, which
regulates ER-Golgi trafficking steps, a 60 residue coiled-coil
domain with homology to t-SNAREs interacts with several(means ± SEM, n = 12–13 cells) is shown for CAPS knockdown, wild-type CAPS
(data not shown).
(G) CAPS downregulation by shRNA decreased CAPS levels by 90%.
(H) Transfection of a pcDNA3.1-CAPS-tagRFP harboring silent mutations into dow
CAPS(D952-997).
CelSNARE proteins and promotes trans SNARE complex formation
(Shorter et al., 2002). Tomosyn, an inhibitory protein for vesicle
exocytosis, harbors a VAMPmotif that may interfere with SNARE
complex formation (Yamamoto et al., 2009). Other tethering
factor complexes involved in membrane fusion events (exocyst,
COG, GARP, Dsl1p) contain subunits that bind SNAREs via
helical domains (Sztul and Lupashin, 2009). Regions in these
tethering factor subunits exhibit an evolutionary relationship to
regions in the CAPS and Munc13 proteins. The helix in the
CAPS MHD1 identified here as part of the SNARE-binding
domain is at the N-terminal end of the tethering factor homology
region (Pei et al., 2009).
While sequences in MHD1 were necessary for CAPS binding
to SNAREs and for CAPS activity in vesicle exocytosis, these
sequences were not sufficient for CAPS activity. This indicates
that additional regions of CAPS are needed to integrate its
SNARE-binding activity with its function in vesicle exocytosis.
Indeed, the PI(4,5)P2-binding PH domain of CAPS was essential
for CAPS stimulation of SNARE complex formation and SNARE-
dependent liposome fusion (James et al., 2009). CAPS appears
to utilize both membrane interactions and SNARE binding to
execute its function. Other domains in CAPS also play essential
but poorly understood roles (Grishanin et al., 2002; Nojiri et al.,
2009; Speese et al., 2007).
The current work expands our understanding of the function of
domains in CAPS and provides a plausible explanation for how
CAPS could promote SNARE complex formation in vesicle
priming. Following plasma membrane recruitment via PH
domain interactions with acidic phospholipids, t-SNARE-binding
sequences in the DAMH domain could engage syntaxin-1 and
SNAP-25 to organize t-SNARE complexes. Subsequently,
binding to t-SNAREs by the DAMH domain may be displaced
by the interaction of overlapping v-SNARE-binding sequences
in the DAMH domain with VAMP-2. This interaction could facili-
tate the entry of VAMP-2 into t-SNARE complexes, possibly
accompanied by CAPS dissociation. This speculative model
for the mechanism of CAPS function will require further
assessment.
EXPERIMENTAL PROCEDURES
Preparation of Liposomes
Proteoliposomes were formed by comicellization or by the extrusion method
(James et al., 2008; Mayer et al., 1986; Weber et al., 1998). For comicelliza-
tion, a lipid film with 1.5 mmol DOPC and 0.25 mmol DOPS was resuspended
with 500 ml SNARE proteins in elution buffer (25 mM HEPES-KOH [pH 7.4],
100 mM KCl, 50 mM imidazole-OAc [pH 7.4], 1.0% b-octylglucoside). Lipid
mixtures contained 2 mCi of [3H]-1,2-dipalmitoyl phosphatidylcholine (NEN,
Cambridge, UK) to determine lipid recoveries and to standardize binding
reactions. Proteoliposomes were dialyzed overnight at 4C in reconstitution
buffer (25 mM HEPES-KOH [pH 7.4], 100 mM KCl, 10% [w/v] glycerol,
1 mM DTT) stirring with Bio-beads (BIO-RAD), mixed with an equal volume
of 80% Nycodenz (a.k.a. Accudenz) (Accurate Chemical and Scientific
Corp, Westbury, NY), overlaid with 30% and 0% Accudenz in reconstitutionrescue, or CAPS(D952-997) re-expression and was similar for wild-type cells
nregulated PC12 cells enabled equivalent re-expression of wild-type CAPS or
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CAPS/UNC31 MHD1 Required for Vesicle Primingbuffer without glycerol and centrifuged at 45,000 rpm for 4 hr at 4C in a SW
50.1 rotor. Proteoliposomes at the 0%–30% Accudenz interface were
collected and flash frozen. For the extrusion method, a lipid film containing
4.5 mmol DOPC and 0.75 mmol DOPS was resuspended in 300 ml of reconsti-
tution buffer, vortexed, frozen-thawed five times, and extruded (MiniExtruder,
Avanti Polar Lipids) with 32 passes through a 0.1 mm Nuclepore track-etched
polycarbonate membrane filter (Whatman) to produce 100 nm diameter pro-
teoliposomes. Aliquots were mixed quickly with two volumes of SNARE
proteins in elution buffer, gently shaken for 30 min, diluted with 1 volume
reconstitution buffer, dialyzed, and separated by gradient centrifugation as
above. SNARE protein content was assessed by SDS-PAGE and Coomassie
staining. Proteoliposomes by extrusion had 5096 copies/mm2 (160 copies/
liposome) of syntaxin/SNAP-25 or 11,465 copies/mm2 (360 copies/lipo-
some) of VAMP-2. Extruded liposomes with thrombin-cleavable syntaxin-
1A/SNAP-25B were treated with human thrombin (Sigma-Aldrich, St. Louis)
at 0.02 units/ml for 2 hr at room temperature and terminated with 2 mM
4-(2-aminoethyl) benzenesulfonylfluoride (Calbiochem Corp) as described
(Parlati et al., 1999). SNAP-25 was crosslinked to extruded liposomes
composed of DOPC:DOPS:MPB-PE (80:15:5) (Avanti Polar Lipids) by incuba-
tion for 1 hr in buffers with TCEP instead of DTT and quenched with 1 mM
b-mercaptoethanol.
Liposome Binding Assay
Protein-free liposomes or liposomes containing syntaxin-1A, SNAP-25,
syntaxin-1A/SNAP-25, or VAMP-2 in reconstitution buffer without glycerol
were incubated with CAPS or CAPS fusion proteins at room temperature for
30 min. Bound and free proteins were separated by Accudenz gradient centri-
fugation at 45,000 rpm for 1–4 hr at 4C, but maximal recovery was achieved
within 30 min. Top fractions were collected and 20,000 DPM recovered lipo-
somes were run on SDS-PAGE for staining with SYPRO Ruby (Invitrogen) or
for western blotting with a polyclonal CAPS antibody, a monoclonal GST anti-
body (Sigma-Aldrich), a polyclonal MBP antibody (New England Biolabs,
Ipswich,MA), amonoclonal syntaxin-1A antibody (Sigma-Aldrich), a polyclonal
VAMP-2 antibody, or a polyclonal SNAP-25 antibody (Life Span Biosciences,
Seattle, WA). Autoradiograms were quantified with a Molecular Dynamics
Densitometer using ImageQuant software. SYPRO Ruby-stained gels were
analyzed on a Typhoon 9410 (Amersham Biosciences, Piscataway, NJ).
Secretion Assays
A permeable PC12 cell assay was used to assess CAPS activity with norepi-
nephrine release measured by rotating disc electrode voltammetry (Grishanin
et al., 2004). For intact cell assays, PC12 cells were transfected to express
brain-derived neurotrophic factor (BDNF)-enhanced green fluorescent protein
(EGFP) as described (Lynch et al., 2008). Images were acquired on a Nikon
TE2000 microscope fitted for TIRF with an Apo TIRF 100X NA 1.45 objective
lens with a CoolSNAP-ES Digital Monochrome CCD Camera or an Evolve
Digital Monochrome emCCD Camera (Photometrics) controlled by Meta-
morph software (Universal Imaging Corp). EGFP was excited at 488 nm and
tagRFP or mKate2 at 543 nm. Two channel images were acquired with
a dual view imaging system (Optical Insights). CAPS was downregulated by
transfection with an shRNA plasmid (Nojiri et al., 2009) targeting nucleotides
3839–3866 of CAPS mRNA. CAPS rescue constructs containing four silent
mutations in the target sequence were subcloned into tagRFP-containing
plasmids (Evrogen, Moscow). Colocalizations were calculated using ImageJ
software (Wayne Rasband, NIH) with a colocalization threshold plugin (Tony
Collins) and are reported as the thresholded Mander’s split colocalization
coefficient (1.0 is perfect colocalization; 0.0 is no colocalization).
Other Methods
Description of materials, DNA constructs, recombinant protein expression,
and purification can be found in Supplemental Information.
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